Citation Impact
Citing Papers
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
2000 Standout
Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002
2007
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
2009 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
2003 Standout
Platelet associated immunoglobulins in primary biliary cirrhosis: a cause of thrombocytopenia?
1985
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease
1997
Megestrol Acetate Stimulates Weight Gain and Ventilation in Underweight COPD Patients
2002
Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP)
2005
Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models
2005
A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction
2010
Carboplatin with cyclophosphamide in patients with advanced ovarian cancer: an efficacy and quality-adjusted survival analysis
1992
Detection of various platelet‐associated immunoglobulins by flow cytometry in idiopathic thrombocytopenic purpura
2005
Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents
1997
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
The Role of Platelets in Antimicrobial Host Defense
1997
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
A Phase II Trial of JM-216 in Cervical Cancer: An NCIC CTG Study
2002
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Guillain-Barré syndrome
2016 Standout
Metabolism and action of amino acid analog anti-cancer agents
1990
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
2007 StandoutNobel
A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF)
2005
Patient‐physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer
2008
Definition and classification of cancer cachexia: an international consensus
2011 Standout
Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura
2000
Soft-Tissue Sarcomas in Adults
2005 Standout
Tailoring Nicotine Replacement Therapy
2006
Response to therapy in 37 patients with HIV‐related thrombocytopenic purpura
1987
Nicotine replacement therapy for smoking cessation
2008
Glutamine Supplementation in Cancer Patients Receiving Bone Marrow Transplantation and High Dose Chemotherapy
2001
Targeting multidrug resistance in cancer
2006 Standout
Genetic thrombocytopenia with autosomal dominant transmission: a review of 54 cases
1990
Transdermal Drug Delivery: Clinical Considerations for the Obstetrician–Gynecologist
2005
Immune Thrombocytopenic Purpura
2002 Standout
Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals
2010
Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.
1991
The pathobiology of mucositis
2004 Standout
Prevention of Venous Thromboembolism
2004 Standout
Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: A prospective randomized clinical trial
1994
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.
1992
Inflammation and cancer: back to Virchow?
2001 Standout
Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): A report on 181 cases
1989
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.
1992 Standout
Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma
1998
Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
2002
Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial
2006
Advances in the diagnosis of idiopathic thrombocytopenic purpura
2000
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
A Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation Pharmacotherapies
2009
Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer.
1995
Weight loss in patients with advanced cancer: effects, causes, and potential management
2008
Infective endocarditis
2004 Standout
Long-Term observation of 208 adults with chronic idiopathic thrombocytopenic purpura
1995
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Tumor Angiogenesis
2008 Standout
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Carboplatin versus cisplatin in solid tumors: An analysis of the literature
1998
Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot study.
1991
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a hellenic co-operative oncology group study
1996
Cancer of the Ovary
2004 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Adult idiopathic thrombocytopenic purpura
1980
Immune Thrombocytopenia
1979
Extracellular DNA traps promote thrombosis
2010 Standout
Studies by Enzyme‐Linked Immunosorbent Assay (ELISA) of Antiplatelet Antibody and Transient Neonatal Thrombocytopenic Purpura*
1983
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Nicotine replacement therapy for smoking cessation
2012 Standout
The effect of maternal steroid administration on fetal platelet count in immunologic thrombocytopenic purpura
1983
What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials
2010
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
1999
Primary Biliary Cirrhosis
1987 Standout
Chronic Immune Thrombocytopenic Purpura in Monozygotic Twins
1982
Hematologic Aspects of Systemic Lupus Erythematosus
1977
Nicotine replacement therapy for smoking cessation
2002
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 StandoutScience
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
2010 Standout
Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
1999
Platelet-associated DNA and anti-DNA antibody in systemic lupus erythematosus with nephritis.
1986
Acute idiopathic thrombocytopenic purpura in children
1979
Low doses v conventional doses of corticoids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults
1988
Carboplatin versus cisplatin
1993
Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura
1984
Usefulness of Fully Automated Measurement of Reticulated Platelets Using Whole Blood
2005
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
2000
Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results
2001
Systematic Review of the Treatment of Cancer-Associated Anorexia and Weight Loss
2005
Idiopathic thrombocytopenia, initial illness and long term follow up.
1984
Nicotine Patch Therapy Based on Smoking Rate Followed by Bupropion for Prevention of Relapse to Smoking
2003
Detection of platelet-associated immunoglobulins by flow cytometry for the diagnosis of immune thrombocytopenia: a prospective study and critical review.
2000
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Treatment of Adult Autoimmune Thrombocytopenic Purpura with High‐Dose Intravenous Plasmin‐Cleaved Gammaglobulins
1983
Platelet-associated IgG in immune thrombocytopenic purpura
1977
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Original article: Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma
1990
Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States
2009
Usefulness of Measurement of Reticulated Platelets for Diagnosis of Idiopathic Thrombocytopenic Purpura
2005
Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpura
1984
Systemic lupus erythematosus and myelofibrosis
1986 StandoutNobel
Meta-analysis of the role of platinum compounds in advanced ovarian carcinoma. The Advanced Ovarian Cancer Trialists Group.
1992
Chronic Immunologic Thrombocytopenic Purpura
1980
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
Splenectomy in the Management of the Thrombocytopenia of the Wiskott–Aldrich Syndrome
1980
Immune Thrombocytopenic Purpura and Pregnancy
1982
Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura
1994
Use of Hematopoietic Colony-Stimulating Factors: Comparison of the 1994 and 1997 American Society of Clinical Oncology Surveys Regarding ASCO Clinical Practice Guidelines
1999
Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders
1990
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
Effect of Danazol in Immune Thrombocytopenic Purpura
1987
Autoimmune thrombocytopenic purpura
1980
Biology of Cachexia
1997
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Idiopathic thrombocytopenic purpura and pregnancy. Maternal platelet count and antiplatelet antibodies do not predict the risk of neonatal thrombocytopenia
1985
DNA Topoisomerases: Structure, Function, and Mechanism
2001 Standout
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
1981 Standout
Vessel injury, platelet adherence, and platelet survival.
1983
Works of Larry P. Ebbert being referenced
Randomized Comparison of a Nicotine Inhaler and Bupropion for Smoking Cessation and Relapse Prevention
2007
Phase II Trial of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced/Recurrent Carcinoma of the Uterine Cervix and Vagina
1995
Phase III Controlled Evaluation of Glutamine for Decreasing Stomatitis in Patients Receiving Fluorouracil (5-FU)-Based Chemotherapy
1999
Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia
1990
A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group
1993
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma
1992
Granulocyte Colony-Stimulating Factor in Severe Chemotherapy-Induced Afebrile Neutropenia
1997
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer
1989
Cyclophosphamide-Cisplatin Versus Cyclophosphamide-Carboplatin in Stage III-IV Ovarian Carcinoma: A Comparison of Equally Myelosuppressive Regimens
1989
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting
2003
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting
2003
Randomized Comparison of a Nicotine Inhaler and Bupropion for Smoking Cessation and Relapse Prevention
2007
Phase II Study of Docetaxel in Advanced Soft Tissue Sarcomas
1996
Quantitative Determination of Antibody in Idiopathic Thrombocytopenic Purpura
1975
Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.
1987